CELC Reports $1.2M Q4 Rev, $0.01 EPS, FDA Accepts NDA for Gedatolisib, Priority Review July 2026, VIKTORIA-1 Topline Data Q2 2026
Celcuity Inc. Common Stock · SERVICES-MEDICAL LABORATORIES · Now $122.96
Post-detection moves
1h
—
1d
—
3d
—
7d
—
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS